These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16159619

  • 21. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.
    Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA.
    Br J Clin Pharmacol; 2003 Apr; 55(4):375-81. PubMed ID: 12680886
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 23. Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma.
    Davis KC, Small RE.
    Pharmacotherapy; 1998 Apr; 18(4):720-8. PubMed ID: 9692646
    [Abstract] [Full Text] [Related]

  • 24. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.
    Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG.
    Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218
    [Abstract] [Full Text] [Related]

  • 25. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner.
    Kawai M, Sakai A, Takaori S, Hiura A, Sakata N, Nakashima M, Miyamoto T.
    Methods Find Exp Clin Pharmacol; 2005 May; 27(6):385-9. PubMed ID: 16179955
    [Abstract] [Full Text] [Related]

  • 26. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 27. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 28. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.
    Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, Choubtum L, Okascharoen C.
    Arch Dis Child; 2004 Nov; 89(11):1055-8. PubMed ID: 15499064
    [Abstract] [Full Text] [Related]

  • 29. Intranasal loteprednol etabonate in healthy male subjects: pharmacokinetics and effects on endogenous cortisol.
    Hermann R, Locher M, Siebert-Weigel M, LaVallee N, Derendorf H, Hochhaus G.
    J Clin Pharmacol; 2004 May; 44(5):510-9. PubMed ID: 15102872
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
    Du XL, Zhu Z, Fu Q, Li DK, Xu WB.
    Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
    [Abstract] [Full Text] [Related]

  • 31. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP, Turcotte H, Prince P, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M.
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [Abstract] [Full Text] [Related]

  • 32. The role of the MDI and DPI in pediatric patients: "Children are not just miniature adults".
    Ahrens RC.
    Respir Care; 2005 Oct; 50(10):1323-8; discussion 1328-30. PubMed ID: 16185368
    [Abstract] [Full Text] [Related]

  • 33. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma.
    Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S.
    J Allergy Clin Immunol; 2007 Apr; 119(4):811-6. PubMed ID: 17320942
    [Abstract] [Full Text] [Related]

  • 34. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
    Adachi M, Aizawa H, Ishihara K, Ohta K, Sano Y, Taniguchi H, Nakashima M.
    Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack.
    Starobin D, Bolotinsky L, Or J, Fink G, Shtoeger Z.
    Isr Med Assoc J; 2008 Jul; 10(8-9):568-71. PubMed ID: 18847151
    [Abstract] [Full Text] [Related]

  • 36. Systemic effect comparisons of six inhaled corticosteroid preparations.
    Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich M, Boushey HA, Cherniack RM, Craig TJ, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kunselman SJ, Lazarus SC, Lemanske RF, Peters SP, Sorkness CA.
    Am J Respir Crit Care Med; 2002 May 15; 165(10):1377-83. PubMed ID: 12016099
    [Abstract] [Full Text] [Related]

  • 37. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT, Zhang TT, Zhou H, Qu XJ, Wu WM, Huang J.
    Respiration; 2007 May 15; 74(1):33-43. PubMed ID: 17008769
    [Abstract] [Full Text] [Related]

  • 38. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
    J Allergy Clin Immunol; 2005 Nov 15; 116(5):1007-13. PubMed ID: 16275368
    [Abstract] [Full Text] [Related]

  • 39. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
    Mehta R, Montembault M, Warren F, Gupta A, Brealey N, Moore A.
    J Aerosol Med Pulm Drug Deliv; 2016 Aug 15; 29(4):386-92. PubMed ID: 26824933
    [Abstract] [Full Text] [Related]

  • 40. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L, Geller D.
    Respir Med; 2005 Jul 15; 99(7):836-49. PubMed ID: 15939245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.